Home
About Us
Our Team
The Urihk Partnership
Products
Antibiotic
Antifungal
Anti-coagulant
Immuno modulator
Neuro/CNS
Services
Learn More
News
Gallery
Careers
Contact Us
Select Page
Tazobactam/piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: comparison with imipenem/cilastatin
This content has been restricted to logged in users only. Please
login
to view this content.